US RESEARCH ROUNDUP-Autodesk, Metlife, Rollins

By Reuters News

- Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Autodesk, Metlife, and Rollins on Monday.

HIGHLIGHTS

* Allstate Corp ALL.N: Piper Sandler cuts target price to $294 from $300

* Autodesk Inc ADSK.O: Jefferies raises target price to $325 from $300

* Metlife MET.N: Piper Sandler raises target price to $115 from $110

* Rollins Inc ROL.N: Citigroup raises to buy from neutral; raises PT to $49 from $32

* Vistra Corp VST.N: CIBC cuts target price to $175 from $181

Following is a summary of research actions on US companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* 10X Genomics TXG.O: JP Morgan cuts target price to $65 from $70

* Adaptive Biotechnologies Corporation ADPT.O: JP Morgan raises PT to $35 from $30

* Advanced Drainage Systems Inc WMS.N: Stephens cuts target price to $155 from $175

* Aflac Incorporated AFL.N: Piper Sandler raises target price to $143 from $138

* Airbnb ABNB.O: Jefferies raises target price to $230 from $215

* Allstate Corp ALL.N: Piper Sandler cuts target price to $294 from $300

* American Financial Group AFG.N: KBW raises target price to $150 from $147

* Amrize AG AMRZ.N: Berenberg cuts to hold from buy; cuts target price to $46 from $48

* Apa Corporation APA.O: Gerdes Energy Research raises target price by $3 to $62

* Assurant Inc AIZ.N: Piper Sandler raises target price to $356 from $329

* Atmus Filtration Technologies ATMU.N: JP Morgan raises target price to $60 from $54

* Autodesk Inc ADSK.O: Jefferies raises target price to $325 from $300

* Axon Enterprise AXON.O: Raymond James cuts target price to $475 from $675

* Bancorp Inc TBBK.O: Piper Sandler cuts target price to $62 from $75

* Berkshire Hathaway BRKa.N: KBW raises target price to $765000 from $735000

* Beta Technologies Inc BETA.N: Jefferies cuts to hold from buy; cuts PT to $27 from $29

* Bioage Labs BIOA.O: Piper Sandler cuts target price to $40 from $73

* Biogen BIIB.O: Piper Sandler raises target price to $305 from $245

* Bkv Corporation BKV.N: Gerdes Energy Research cuts target price by $4 to $24

* Box Inc BOX.N: RBC raises target price to $35 from $26

* Brookfield Asset Management Ltd BAM.N: Piper Sandler raises PT to $52 from $49

* Cardinal Health CAH.N: TD Cowen raises target price to $304 from $280

* CF Industries Holdings Inc CF.N: RBC raises target price to $125 from $115

* Cigna CI.N: Leerink Partners raises target price to $315 from $300

* Conocophillips COP.N: Gerdes Energy Research raises target price by $2 to $160

* Curtiss-Wright Corporation CW.N: Piper Sandler cuts target price to $544 from $586

* Curtiss-Wright Corporation CW.N: Stifel cuts target price to $472 from $518

* Delek US Holdings Inc DK.N: Raymond James cuts target price to $95 from $100

* Devon Energy Corporation DVN.N: JP Morgan raises target price to $68 from $65

* Draftkings DKNG.O: Canaccord Genuity cuts target price to $30 from $40

* Draftkings DKNG.O: JP Morgan cuts to neutral from overweight; cuts PT to $21 from $30

* Draftkings DKNG.O: Truist Securities cuts target price to $22 from $26

* Duolingo DUOL.O: Jefferies raises target price to $175 from $145

* Dxp Enterprises DXPE.O: Stephens cuts target price to $200 from $220

* EOG Resources EOG.N: JP Morgan raises target price to $170 from $164

* Eupraxia Pharmaceuticals : RBC initiates coverage with outperform rating; PT $14

* Expedia Group EXPE.O: Jefferies cuts target price to $325 from $350

* Figure Technology Solutions FIGR.O: KBW cuts target price to $37 from $45

* First Solar FSLR.O: Piper Sandler cuts target price to $222 from $251

* Generac Holdings GNRC.N: Piper Sandler cuts target price to $266 from $279

* Globus Medical GMED.N: Truist Securities cuts target price to $90 from $100

* Helios Technologies Inc HLIO.N: Stifel cuts target price to $65 from $78

* Hmh Holding Inc HMH.O: Piper Sandler cuts target price to $26 from $32

* Humana HUM.N: Leerink Partners raises target price to $583 from $513

* Humana HUM.N: Piper Sandler raises target price to $526 from $463

* Iambic Therapeutics IAM.O: JP Morgan starts coverage with overweight rating; PT $22

* Installed Building Products IBP.N: Stephens raises target price to $230 from $200

* Insulet Corporation PODD.O: Truist Securities raises target price to $160 from $153

* ITT Inc ITT.N: Stifel raises target price to $259 from $256

* Jazz Pharmaceuticals Plc JAZZ.O: Bernstein cuts target price to $220 from $229

* Karman Holdings Inc KRMN.N: Raymond James cuts target price to $75 from $100

* Kratos Defense & Security Solutions KTOS.O: Canaccord Genuity cuts PT to $120 from $135

* Kratos Defense & Security Solutions KTOS.O: Raymond James cuts PT to $90 from $144

* Mastec Inc MTZ.N: Piper Sandler cuts target price to $269 from $313

* Metlife MET.N: Piper Sandler raises target price to $115 from $110

* Mettler-Toledo International MTD.N: Jefferies raises target price to $1930 from $1580

* Mettler-Toledo International MTD.N: JP Morgan raises target price to $1725 from $1550

* Mettler-Toledo International MTD.N: RBC raises target price to $1790 from $1515

* Moderna MRNA.O: Jefferies raises target price to $230 from $200

* Moderna MRNA.O: Piper Sandler raises target price to $305 from $230

* Moderna MRNA.O: RBC raises target price to $145 from $130

* Moderna MRNA.O: TD Cowen raises target price to $110 from $90

* Molson Coors Beverage Company TAP.N: JP Morgan cuts target price to $37 from $41

* Molson Coors Beverage Company TAP.N: JP Morgan cuts to underweight from neutral

* Mp Materials Corp MP.N: Canaccord Genuity cuts target price to $70 from $82

* Nelnet NNI.N: TD Cowen raises target price to $135 from $125

* Nextpower Inc NXT.O: Piper Sandler raises target price to $115 from $110

* Oklo OKLO.N: Canaccord Genuity cuts target price to $66 from $100

* Oklo Inc OKLO.N: HSBC cuts target price to $38 from $70

* Ormat Technologies Inc ORA.N: Piper Sandler cuts target price to $120 from $142

* Owens Corning OC.N: Jefferies cuts target price to $145 from $165

* Paylocity Holding Corp PCTY.O: TD Cowen raises target price to $205 from $178

* Primoris Services Corporation PRIM.N: Piper Sandler cuts target price to $80 from $90

* Procore Technologies Inc PCOR.N: Jefferies raises target price to $105 from $75

* Qnity Electronics Q.N: RBC cuts target price to $152 from $160

* Quanta Services Inc PWR.N: Piper Sandler cuts target price to $701 from $714

* Rb Global : Stephens cuts target price to $103 from $111

* Reinsurance Group of America RGA.N: Piper Sandler ups PT to $300 from $274

* Relay Therapeutics RLAY.O: Jonestrading raises target price to $31 from $20

* Rollins Inc ROL.N: Citigroup raises to buy from neutral; raises PT to $49 from $32

* Six Flags Entertainment Corp FUN.N: JP Morgan cuts target price to $12 from $22

* Snap Inc SNAP.N: HSBC cuts target price to $5.42 from $6

* Targa Resources Corp. TRGP.N: Jefferies cuts target price to $311 from $326

* Teleflex Incorporated TFX.N: Truist Securities raises target price to $167 from $142

* The Hanover Insurance Group THG.N: KBW raises target price to $248 from $223

* Tripadvisor TRIP.O: Jefferies raises to hold from underperform; cuts PT to $7 from $8

* Tronox Holdings Plc TROX.N: JP Morgan raises to neutral from underweight

* Unum Group UNM.N: JP Morgan raises to overweight from neutral

* Unum Group UNM.N: JP Morgan ups PT to $90 from $98

* Veeva Systems VEEV.N: Canaccord Genuity raises target price to $315 from $260

* Vera Therapeutics VERA.O: Raymond James raises target price to $87 from $84

* Vericel Corporation VCEL.O: Truist Securities raises target price to $65 from $52

* Viasat Inc VSAT.O: JP Morgan cuts target price to $120 from $130

* Viasat Inc VSAT.O: Needham cuts target price to $85 from $105

* Vistra Corp VST.N: CIBC cuts target price to $175 from $181

* Vse Corp VSEC.O: Jefferies cuts target price to $245 from $275

* Watts Water Technologies WTS.N: Stifel cuts target price to $430 from $445

* Zimmer Biomet Holdings ZBH.N: Leerink Partners raises target price to $110 from $97

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.